Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Expert Opinion on Drug Safety
|
September 19, 2017
Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma
E Grande, H Glen, J Aller, et al.
European Journal of Medical Research
|
August 11, 2010
Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma
B Schlenker, M Seitz, M J Bader, et al.
The Journal of Urology
|
August 24, 2013
A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study
A Karl, A Buchner, A Becker, et al.
Urology
|
March 16, 2020
Advanced Molecular Imaging in Histologically Verified Metanephric Adenoma
L M Mittlmeier, M Unterrainer, A Todica, et al.
World Journal of Urology
|
May 13, 2022
Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group
V Grünwald, L Bergmann, B Brehmer, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
January 13, 2016
Renal Pseudoaneurysms and Arteriovenous Fistulas as a Complication of Nephron-Sparing Partial Nephrectomy: Technical and Functional Outcomes of Patients Treated With Selective Microcoil Embolization During a Ten-Year Period
F F Strobl, M D'Anastasi, R Hinzpeter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2011
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings
J Beck, G Procopio, E Bajetta, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 28, 2020
<sup>18</sup>F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results
L M Mittlmeier, M Unterrainer, S Rodler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2013
A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN
B Melichar, S Bracarda, V Matveev, et al.
British Journal of Cancer
|
May 15, 2014
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
B Escudier, M D Michaelson, R J Motzer, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Expert Opinion on Drug Safety
|
September 19, 2017
Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma
E Grande, H Glen, J Aller, et al.
European Journal of Medical Research
|
August 11, 2010
Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma
B Schlenker, M Seitz, M J Bader, et al.
The Journal of Urology
|
August 24, 2013
A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study
A Karl, A Buchner, A Becker, et al.
Urology
|
March 16, 2020
Advanced Molecular Imaging in Histologically Verified Metanephric Adenoma
L M Mittlmeier, M Unterrainer, A Todica, et al.
World Journal of Urology
|
May 13, 2022
Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group
V Grünwald, L Bergmann, B Brehmer, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
January 13, 2016
Renal Pseudoaneurysms and Arteriovenous Fistulas as a Complication of Nephron-Sparing Partial Nephrectomy: Technical and Functional Outcomes of Patients Treated With Selective Microcoil Embolization During a Ten-Year Period
F F Strobl, M D'Anastasi, R Hinzpeter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2011
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings
J Beck, G Procopio, E Bajetta, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 28, 2020
<sup>18</sup>F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results
L M Mittlmeier, M Unterrainer, S Rodler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2013
A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN
B Melichar, S Bracarda, V Matveev, et al.
British Journal of Cancer
|
May 15, 2014
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
B Escudier, M D Michaelson, R J Motzer, et al.
Page
of 6